World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Keywords:
Novo Nordisk faces increasing competition in the rapidly growing diabetes market.
Denmark's pharmaceutical maker Novo Nordisk strategies
02/12/2013
Grouped Articles
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
Wall Street Journal 06/17/2014
Novo Nordisk's Comeback Needs Nods From Regulators
Wall Street Journal 09/03/2014
Novo Nordisk’s Insulin Move Is Right Medicine
Wall Street Journal 03/29/2015
Wall Street Journal 02/12/2013
Novo Nordisk performance
02/12/2013
Grouped Articles
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
Wall Street Journal 06/17/2014
Novo Nordisk's Comeback Needs Nods From Regulators
Wall Street Journal 09/03/2014
Novo Nordisk’s Insulin Move Is Right Medicine
Wall Street Journal 03/29/2015
Wall Street Journal 02/12/2013
Sanofi and new diabetes drugs
04/09/2010
Grouped Articles
Sanofi Expands Diabetes Efforts With Licensing Deal
Wall Street Journal 04/09/2010
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Sticking Point: Sanofi’s Diabetes Franchise Is Crucial to Sorting Out a Mess
Wall Street Journal 11/07/2014
How a Sanofi Diabetes Bet Went Wrong
Wall Street Journal 02/10/2016
Sanofi strategies
04/09/2010
Grouped Articles
Sanofi Expands Diabetes Efforts With Licensing Deal
Wall Street Journal 04/09/2010
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Sanofi's MS Drug Lemtrada Receives Approval in Europe
Wall Street Journal 09/17/2013
Sanofi Buys TargeGen, Boosting Oncology Pipeline
Wall Street Journal 07/01/2010
Sanofi Makes Public a $18.5 Billion Bid for Genzyme
New York Times 08/29/2010
Sanofi Fires CEO as Tensions Boil Over
Wall Street Journal 10/30/2014
Eli Lilly strategies
01/15/2009
Grouped Articles
Lilly Plans to Lay Off 30% of Its Sales Reps
Wall Street Journal 04/12/2013
Eli Lilly's Drug Assembly Line
BusinessWeek 02/25/2010
Eli Lilly Enters Unusual Patent Dispute
Wall Street Journal 08/18/2013
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Eli Lilly, Unlike Rivals, Isn't Pulling Back on R&D
Wall Street Journal 10/21/2013
Eli Lilly Sets Plans for Emerging Markets
Wall Street Journal 06/08/2010
Novo Nordisk management
02/12/2013
Grouped Articles
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
Wall Street Journal 06/17/2014
Novo Nordisk's Comeback Needs Nods From Regulators
Wall Street Journal 09/03/2014
Novo Nordisk’s Insulin Move Is Right Medicine
Wall Street Journal 03/29/2015
Wall Street Journal 02/12/2013
Novo Nordisk and increasing competition in the diabetes market
08/25/2013
Grouped Articles
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
Wall Street Journal 06/17/2014
Novo Nordisk's Comeback Needs Nods From Regulators
Wall Street Journal 09/03/2014
Novo Nordisk’s Insulin Move Is Right Medicine
Wall Street Journal 03/29/2015
Sanofi performance
08/29/2010
Grouped Articles
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Sanofi's MS Drug Lemtrada Receives Approval in Europe
Wall Street Journal 09/17/2013
Sanofi Makes Public a $18.5 Billion Bid for Genzyme
New York Times 08/29/2010
Sanofi Fires CEO as Tensions Boil Over
Wall Street Journal 10/30/2014
Sanofi Fires Its Chief Executive but Retains His Global Strategy
New York Times 10/29/2014
Sticking Point: Sanofi’s Diabetes Franchise Is Crucial to Sorting Out a Mess
Wall Street Journal 11/07/2014
Eli Lilly performance
01/31/2008
Grouped Articles
Lilly Plans to Lay Off 30% of Its Sales Reps
Wall Street Journal 04/12/2013
Eli Lilly's Drug Assembly Line
BusinessWeek 02/25/2010
Eli Lilly Enters Unusual Patent Dispute
Wall Street Journal 08/18/2013
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Eli Lilly, Unlike Rivals, Isn't Pulling Back on R&D
Wall Street Journal 10/21/2013
Lilly Diabetes Drug Ruled Comparable to Market Leader
Wall Street Journal 02/25/2014
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
